Mylan's US$28.9b offer to fellow drugmaker
It has offered to buy Perrigo, which makes skin gels, nasal sprays and injectables
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
New York
MYLAN has offered to buy fellow drugmaker Perrigo for US$28.9 billion, a deal that would create a powerhouse for generic medicine.
Mylan, which makes about 1,400 medications, offered US$205 a share in cash and stock for Perrigo, according to a statement on Wednesday. That represents a 25 per cent premium over Tuesday's closing price for Perrigo, which makes a range of products including skin gels, injectables and nasal sprays. Perrigo said that its board will meet to discuss the proposal and that there's no certainty that an offer will be made.
Copyright SPH Media. All rights reserved.
